Pediatrix Medical Group, Inc.(MD)Earnings, Financials & Key RatiosPediatrix Medical Group, Inc. (MD) stock price & volume — 10-year historical chart
Investment Thesis • Updated 2026Q1
while the forward P/E of 10.81 suggests a modest valuation, the extreme volatility in operating cash flow and the persistent negative retained earnings of $53.6M warrant a cautious, wait-and-see approach.
Pediatrix Medical Group, Inc. (MD) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Pediatrix Medical Group, Inc. (MD) EPS & revenue vs analyst estimates — last 4 quarters
| Quarter | Date | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|---|
| Q2 2026Latest | May 5, 2026 | $0.44vs $0.37+18.9% | $476Mvs $466M+2.2% |
| Q1 2026 | Feb 19, 2026 | $0.50vs $0.53-5.7% | $494Mvs $486M+1.6% |
| Q4 2025 | Nov 3, 2025 | $0.67vs $0.46+45.7% | $493Mvs $486M+1.4% |
| Q3 2025 | Aug 5, 2025 | $0.53vs $0.42+26.2% | $469Mvs $474M-1.0% |
Recent stock market news and headlines for Pediatrix Medical Group, Inc. (MD)
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
JACKSONVILLE BEACH, Fla.--(BUSINESS WIRE)--MedAxiom, the premier source for cardiovascular organizational performance solutions, has released the 2025 Cardiovascular Advanced Practice Provider (APP) Compensation and Utilization Report, which includes data from more than 100 provider organizations. The report features a foreword from Jerry Blackwell, MD, MBA, FACC, president and CEO of MedAxiom, highlighting APP contributions to productivity, workflow, access, and patient satisfaction, enabling.
OWINGS MILLS, MD, June 22, 2026 (GLOBE NEWSWIRE) -- The National Capital Chesapeake Bay Chapter of the National Academy of Television Arts & Sciences presented Maryland Public Television with 20 Emmys during its 68th Capital Emmy® Awards ceremony at the Bethesda North Marriott Hotel and Conference Center on Saturday, June 20. NATAS-NCCB comprises television industry professionals dedicated to fostering and recognizing outstanding achievements in television production in Maryland, Virginia, and Washington, D.C.
George Hill, Anguilla, 17 June 2026 -- As competition for medical school places in the United Kingdom reaches unprecedented levels, New Anglia University is providing aspiring doctors with an alternative pathway to medical education through its UK-aligned Doctor of Medicine (MD) programme, which combines an integrated curriculum with extensive NHS-based clinical rotations. The University's approach comes at a time when demand for medical school places continues to significantly exceed available capacity, leaving thousands of qualified applicants without a place each year despite strong academic credentials and a clear commitment to pursuing a career in medicine.
Key metrics vs top competitors for Pediatrix Medical Group, Inc. (MD)
| Company | Price | Market Cap | P/E Ratio | Rev Growth (1Y) | Net Margin | ROE | Div Yield |
|---|---|---|---|---|---|---|---|
| $27.39 | $2.28B | 14.12 | -4.92% | 8.64% | 20.28% | — | |
| $191.20 | $16.75B | 12.34 | 3.12% | 7.94% | 19.56% | — | |
| $73.15 | $1.43B | -7.52 | -43.89% | -284.18% | -87% | — | |
| $34.65 | $651.24M | 14.03 | 2.63% | 14.27% | 9.68% | — | |
| $417.07 | $92.52B | 14.70 | 7.08% | 8.89% | — | — | |
| $158.05 | $9.89B | 6.84 | 9.71% | 8.56% | 20.65% | — |
Pediatrix Medical Group, Inc. (MD) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
Pediatrix Medical Group, Inc. (MD) SEC filings — annual & quarterly reports (10-K, 10-Q)
May 7, 2026·SEC
May 5, 2026·SEC
Feb 19, 2026·SEC
Get notified when MD posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
Pediatrix Medical Group, Inc. (MD) stock FAQ — growth, dividends, profitability & financials explained
Pediatrix Medical Group, Inc. (MD) reported $1.93B in revenue for fiscal year 2025. This represents a 2291% increase from $80.8M in 1996.
Pediatrix Medical Group, Inc. (MD) saw revenue decline by 4.9% over the past year.
Yes, Pediatrix Medical Group, Inc. (MD) is profitable, generating $174.2M in net income for fiscal year 2025 (8.6% net margin).
Pediatrix Medical Group, Inc. (MD) has a return on equity (ROE) of 20.3%. This is excellent, indicating efficient use of shareholder capital.
Pediatrix Medical Group, Inc. (MD) generated $237.7M in free cash flow for fiscal year 2025. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.
